当代抗逆转录病毒方案随机试验中的 emergent HIV-1 耐药
本文讨论抗逆转录病毒治疗中 virological failure 与 emergent HIV-1 耐药的关系,指出耐药风险受方案组成及内在耐药屏障影响,应视为方案相关不良效应在临床试验中与病毒学和安全性终点同等考量。作者提出建立系统框架对试验中 emergent 耐药进行分类,并标准化耐药评估及向监管机构报告,以改善对方案特异性耐药风险的理解并辅助临床决策。
要点
- virological failure 在部分个体中不可避免,历史上主要受口服治疗依从性不佳影响。
- 选择 1 类或 2 类 HIV 耐药的风险受方案组成影响,不同方案内在耐药屏障差异显著。
- 非劣效且 virological failure 率相似的方案,emergent HIV 耐药情况仍可能不同。
核心结论
- 治疗中出现的 HIV 耐药可视为方案相关不良效应,临床试验中应与病毒学和安全性终点同等考量。
主要发现
- virological failure 在部分个体中不可避免,历史上主要受口服治疗依从性不佳影响。
- 选择 1 类或 2 类 HIV 耐药的风险受方案组成影响,不同方案内在耐药屏障差异显著。
- 非劣效且 virological failure 率相似的方案,emergent HIV 耐药情况仍可能不同。
临床怎么用
- 临床试验中应标准化 emergent HIV 耐药评估并向监管机构报告,以更好理解方案特异性耐药风险并辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The occurrence of virological failure in a subset of individuals is an inevitable aspect of antiretroviral treatment, and historically has been primarily influenced by suboptimal adherence to oral therapies. The risk of selecting 1- or 2-class human immunodeficiency virus (HIV) drug resistance is influenced by the composition of the regimen, differing significantly depending on the intrinsic barrier to resistance of the regimen. HIV resistance emergence during treatment can be viewed as a regimen-related adverse effect that warrants equal consideration in clinical trials alongside virological and safety endpoints. Antiretroviral regimens demonstrating non-inferiority and showing similar rates of virological failure can nonetheless differ in terms of HIV emergent resistance. We propose the development of a systematic framework to categorize emergent HIV drug resistance in clinical trials. Standardizing the evaluation of resistance in clinical trials and its reporting to regulatory agencies will facilitate an improved understanding of regimen-specific resistance risks and better inform clinical decision making.
引用
- Llibre JM, Ripamonti D, Geretti AM, et al. Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens. Clin Infect Dis. 2026. PMID: 40985680. doi:10.1093/cid/ciaf471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。